会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • HUMAN TRYPSINOGEN WITH REDUCED AUTOACTIVATION AND ITS USE IN AN IMMUNOASSAY
    • 具有降低自动机能的人类免疫调节因子及其在免疫中的应用
    • US20160237419A1
    • 2016-08-18
    • US15026604
    • 2014-09-25
    • UNIVERSITÄT LEIPZIG
    • Karin BUTTNERAgneta PRASSEThole ZUCHNER
    • C12N9/76G01N33/542C12Q1/37
    • C12N9/6427C12Q1/37C12Y304/21004G01N33/542
    • The present invention relates to a polypeptide consisting of or comprising a variant of human trypsinogen-1, comprising the substitutions: amino acid residue E64 is replaced with an amino acid residue comprising a positively charged side chain, amino acid residue K123 is replaced with an amino acid residue comprising an aliphatic side chain and amino acid residues Y139 and D147 are replaced with a glutamine or asparagine residue, and wherein said variant is further characterized in that: an amino acid residue selected from E16, E17 and E142 is replaced with an amino acid residue comprising an aliphatic side chain, and/or amino acid residue N18 is replaced with a histidine residue, and/or amino acid residue R107 is replaced with a lysine residue, and/or amino acid residue D138 is replaced with an amino acid residue comprising a positively charged side chain, and wherein said variant is cleavable into a polypeptide having a native-like enzymatic activity when compared to human trypsin-1.
    • 本发明涉及由人胰蛋白酶原-1的变体组成或包含人胰蛋白酶原-1变体的多肽,其包含取代:氨基酸残基E64被包含带正电侧链的氨基酸残基替代,氨基酸残基K123被氨基酸 包含脂肪族侧链的酸残基和氨基酸残基Y139和D147被谷氨酰胺或天冬酰胺残基替代,并且其中所述变体的特征还在于:选自E16,E17和E142的氨基酸残基被氨基酸 包含脂族侧链的残基和/或氨基酸残基N18被组氨酸残基取代,和/或氨基酸残基R107被赖氨酸残基替代,和/或氨基酸残基D138被氨基酸残基替代, 带正电的侧链,并且当与人胰蛋白酶-1相比时,所述变体可切割成具有天然样酶活性的多肽。